Matches in Wikidata for { <http://www.wikidata.org/entity/Q64836545> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q64836545 description "clinical trial" @default.
- Q64836545 description "ensayu clínicu" @default.
- Q64836545 description "klinisch onderzoek" @default.
- Q64836545 description "клінічне випробування" @default.
- Q64836545 name "A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors" @default.
- Q64836545 name "A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors" @default.
- Q64836545 type Item @default.
- Q64836545 label "A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors" @default.
- Q64836545 label "A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors" @default.
- Q64836545 prefLabel "A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors" @default.
- Q64836545 prefLabel "A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors" @default.
- Q64836545 P1132 Q64836545-EACB1E4E-F0AA-4DDB-AB76-4FEDDA12C2AC @default.
- Q64836545 P1476 Q64836545-D63D5C4C-F9A0-43BA-9589-12BE86851B43 @default.
- Q64836545 P17 Q64836545-06CB43C1-06AE-4B38-B224-9BDFAF68B55A @default.
- Q64836545 P17 Q64836545-EE7B2C97-77B6-4FB0-A94E-F2856CDF1AD3 @default.
- Q64836545 P2899 Q64836545-BDE5789C-8D71-4ED5-898B-5178AD0C0271 @default.
- Q64836545 P3098 Q64836545-4BA878CD-14F1-40CE-ABBE-BFDC2479CE83 @default.
- Q64836545 P31 Q64836545-D3345420-42BB-4860-B489-3B7232BF8152 @default.
- Q64836545 P580 Q64836545-FFA5A349-68E6-46BD-8C6D-8FC2911B7E8D @default.
- Q64836545 P582 Q64836545-F4F8464A-CF92-450C-A4A6-CB57751445E8 @default.
- Q64836545 P6099 Q64836545-C8EAE3E6-3153-414D-8B27-97076D1F3BF9 @default.
- Q64836545 P6153 Q64836545-08F6981D-AF13-4C54-A19F-8D7165863708 @default.
- Q64836545 P6153 Q64836545-85E51BCD-41F1-40AD-8C28-99965B74B48C @default.
- Q64836545 P6153 Q64836545-8B0D2F48-71B0-4D7C-9C80-03F20B2AC1DC @default.
- Q64836545 P6153 Q64836545-9DDD65DF-B814-4C6C-9969-5DD754BB96DD @default.
- Q64836545 P8363 Q64836545-E49B4F60-BD45-4E05-9916-876641FE2116 @default.
- Q64836545 P1132 "+160" @default.
- Q64836545 P1476 "An Open-Label, Phase 2, Parallel Arm Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 Single Agent in Patients With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors" @default.
- Q64836545 P17 Q17 @default.
- Q64836545 P17 Q30 @default.
- Q64836545 P2899 "+18" @default.
- Q64836545 P3098 "NCT03261947" @default.
- Q64836545 P31 Q30612 @default.
- Q64836545 P580 "2017-10-25T00:00:00Z" @default.
- Q64836545 P582 "2019-11-19T00:00:00Z" @default.
- Q64836545 P6099 Q42824440 @default.
- Q64836545 P6153 Q30286943 @default.
- Q64836545 P6153 Q55454195 @default.
- Q64836545 P6153 Q7896014 @default.
- Q64836545 P6153 Q7934403 @default.
- Q64836545 P8363 Q78089383 @default.